NEW YORK (GenomeWeb News) – McGill University researchers have received more than C$5 million ($4.9 million) in funding to launch a project that will seek to develop genetic biomarkers for use in treating and improving the quality of life in children with brain cancer, McGill said yesterday.

The researchers plan to develop and deploy a diagnostic test in clinical trials that identifies genetic mutations in glioblastoma patients that could be used to plan treatment strategies and improve quality of life.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.